Skip to Content

Interpace Biosciences Inc IDXG

Rating as of

Morningstar’s Analysis

There is no Morningtar’s Analysis data available.

Company Profile

Business Description

Interpace Biosciences Inc is engaged in the life sciences industry. It provides complex molecular analysis for the early diagnosis and treatment of cancer and supporting the development of targeted therapeutics. It operates under one segment which is the business of developing and selling diagnostic clinical and pharma services.

300 Interpace Parkway, Morris Corporate Center 1, Building C
Parsippany, NJ, 07054
T +1 855 776-6419
Sector Healthcare
Industry Diagnostics & Research
Most Recent Earnings Sep 30, 2021
Fiscal Year End Dec 31, 2021
Stock Type Speculative Growth
Employees 152